FDA Integrated Review for Voxzogo sNDA 214938/S002 Approval 10/20/2023

FDA Integrated Review for Voxzogo sNDA 214938/S002 Approval 10/20/2023

Regular price $69.00 USD
Regular price Sale price $69.00 USD
Sale Sold out
Original Request: We request the Integrated Review document for the Voxzogo (vosoritide) sNDA 214938/S002 which was approved on 20-Oct-2023. Please provide the documents electronically if possible.
Tags: Pharma, NDA, 2023
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details